36 independently checked trend briefs about this subject, newest first.
headlinez.news detected 36 source-qualified news clusters connected to Clinical Trials between June 23, 2026 and July 24, 2026. They span 2 newsroom categories and average 7.1 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
The first human participant has received an experimental vaccine targeting the Bundibugyo ebolavirus strain as clinical trials launch in the DRC.
A report reveals the death of a 6-year-old child following an experimental gene-editing treatment in China that was not disclosed to the public.
Kalshi has introduced new prediction markets that allow users to place wagers on the outcomes of clinical trials and pending FDA drug decisions.
Recent research and medical commentary explore the evolving role of GLP-1 receptor agonists in oncology, sparking debate over their efficacy and risks.
Q32 Bio shares surge following the release of 36-week clinical trial data for its alopecia areata treatment, bempikibart.
Biogen’s experimental tau-targeting drug, diranersen, has triggered market volatility following the release of mixed clinical trial data.
A clinical trial indicates that non-invasive brain stimulation therapy can produce significant antidepressant effects within a 10-day period.
Medical experts report promising clinical results for a new pancreatic cancer treatment targeting KRAS-mutated tumors.
Biogen’s tau-targeting Alzheimer’s drug shows early promise in slowing cognitive decline, sparking fresh debate in dementia research
UCSF has commenced patient screening for a new clinical trial investigating whether combining two drugs offers superior results for Alzheimer’s disease.
A new oral GLP-1 agonist pill outperforms Ozempic in clinical trials, reshaping obesity treatment
Breakthroughs in knee pain relief and superconductors dominate this week’s science trends
AI-driven biotech acquisition accelerates Parkinson’s stem cell therapy into clinical trials
Two widely available drugs show *limited* promise for long-COVID fatigue—raising cautious hope for millions.
A personalized cancer vaccine targeting glioblastoma mutations enters clinical trials, showing potential for extended patient survival.
A pancreatic cancer pill under accelerated review could redefine treatment—and early detection—of a deadly disease.
A widely used gym supplement is now under scrutiny for potential mental health benefits—could creatine become a depression treatment?
Compass Pathways' psychedelic depression drug shows promise but faces investor skepticism ahead of key filings
GLP-1 drugs are sparking bold predictions—from addiction treatment to personality shifts—reshaping health debates
BCG vaccine linked to unexpected shifts in brain immunity and Alzheimer’s biomarkers—raising questions about its potential role in neurodegeneration.
A clinical trial for Bundibugyo Ebola treatments is underway in the Democratic Republic of Congo as the regional outbreak intensifies.
DR Congo launches first clinical trials and treatment centers for a novel Ebola strain with no existing cure
A nonsurgical procedure for knee osteoarthritis is gaining attention following reports of significant pain reduction over a 12-month period.
Roche's experimental KRAS inhibitor has outperformed current standard treatments in a head-to-head late-stage clinical trial for lung cancer.
Recent reviews are examining the potential of creatine as an add-on therapy for depression, yielding varied results across clinical trials.
Shares of French biotech firm Abivax have surged following the release of new clinical safety data regarding its experimental ulcerative colitis medication.
A new study indicates that omega-3 fish oil supplements may not provide the cognitive or brain health benefits previously expected.
Stem cell breakthrough in Type 1 diabetes sparks global trial expansion—could insulin injections become obsolete?
A new study indicates that vitamin B therapies may offer potential in the treatment of lethal brain cancers.
Experimental drug daraxonrasib is drawing attention for its performance in clinical trials targeting advanced pancreatic cancer.
The United States is shipping experimental antiviral treatments to the Democratic Republic of Congo to support upcoming clinical trials for the Ebola outbreak.
Researchers have launched the first human clinical trial for an experimental gene therapy designed to reverse the biological aging of cells.
First human trials of a brain implant designed to detect cancer begin in the US
A new blood test could double prostate cancer detection rates, reshaping early screening
The Department of Health and Human Services has initiated a wide-ranging effort to accelerate clinical trials and reclaim American leadership in biotech.
Pfizer’s experimental lung cancer drug sigvotatug vedotin has failed to meet its primary objective in a late-stage clinical trial.